Skip to main content
. 2022 Dec 29;28(1):290. doi: 10.3390/molecules28010290

Table 2.

Assessment of size, weight and ROW of prostate after EFD treatment.

Groups Weight of Whole Epididymis (g) Weight of Both Testes (g) Weight of Prostate (g) Final Body Weight (g) ROW
Control 0.459 ± 0.007 bc 2.25 ± 0.12 b 0.385 ± 0.03 d 213 ± 8.0 c 0.180 ± 0.006 c
Vehicle (10 % DMSO) 0.456 ± 0.021 b 2.23 ± 0.18 b 0.379 ± 0.02 d 208 ± 11 b 0.182 ± 0.008 c
BPA (50 mg/kg) 0.334 ± 0.007 a 1.68 ± 0.29 a 0.478 ± 0.08 a 174 ± 13.0 a 0.274 ± 0.019 a
EFD (10 mg/kg) 0.468 ± 0.056 c 2.32 ± 0.18 c 0.388 ± 0.06 d 221 ± 9.0 d 0.175 ± 0.008 d
BPA + EFD (10 mg/kg) 0.462 ± 0.063 bc 2.28 ± 0.11 bc 0.404 ± 0.05 c 221 ± 8.0 d 0.182 ± 0.008 c
BPA + EFD (05 mg/kg) 0.454 ± 0.043 b 2.26 ± 0.17 b 0.429 ± 0.04 b 215 ± 10.0 c 0.199 ± 0.010 b

Note: ROW, relative organ weight, BPA, Bisphenol A. Data values represent Mean ± SD (n = 7). Means with dissimilar superscript (a–d) letters in the column are significantly (p < 0.05) different from one another.